Congenital adrenal hyperplasia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 50: | Line 50: | ||
'''Prevention:''' [[Congenital adrenal hyperplasia primary prevention|Primary prevention]] | [[Congenital adrenal hyperplasia secondary prevention|Secondary prevention]] | '''Prevention:''' [[Congenital adrenal hyperplasia primary prevention|Primary prevention]] | [[Congenital adrenal hyperplasia secondary prevention|Secondary prevention]] | ||
== | ==Case Studies== | ||
:[[Congenital adrenal hyperplasia case study one|Case #1]] | |||
==See also== | |||
== | |||
*[[Ambiguous genitalia]] | *[[Ambiguous genitalia]] | ||
*[[Female pseudohermaphroditism]] | *[[Female pseudohermaphroditism]] | ||
*[[Adrenal insufficiency]] | *[[Adrenal insufficiency]] | ||
Revision as of 20:23, 24 August 2012
For patient information click here
Congenital adrenal hyperplasia | |
![]() | |
---|---|
Cortisol | |
ICD-10 | E25.0 |
ICD-9 | 255.2 |
OMIM | 201910 201710 202110 201810 202010 |
DiseasesDB | 1854 Template:DiseasesDB2 Template:DiseasesDB2 Template:DiseasesDB2 Template:DiseasesDB2 |
MedlinePlus | 000411 |
MeSH | D000312 |
Congenital adrenal hyperplasia main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Congenital Adrenal Hyperplasia from other Diseases
Epidemiology and Demographics
Risk factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical therapy: 21-Hydroxylase | 11-Hydroxylase
Surgical therapy: Surgery
Prevention: Primary prevention | Secondary prevention
Case Studies
See also